Logo image of PLAB

PHOTRONICS INC (PLAB) Stock Fundamental Analysis

NASDAQ:PLAB - Nasdaq - US7194051022 - Common Stock - Currency: USD

17.43  +0.49 (+2.89%)

After market: 17.53 +0.1 (+0.57%)

Fundamental Rating

6

Overall PLAB gets a fundamental rating of 6 out of 10. We evaluated PLAB against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. PLAB gets an excellent profitability rating and is at the same time showing great financial health properties. A decent growth rate in combination with a cheap valuation! Better keep an eye on PLAB. These ratings would make PLAB suitable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year PLAB was profitable.
PLAB had a positive operating cash flow in the past year.
PLAB had positive earnings in each of the past 5 years.
In the past 5 years PLAB always reported a positive cash flow from operatings.
PLAB Yearly Net Income VS EBIT VS OCF VS FCFPLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

The Return On Assets of PLAB (8.64%) is better than 77.27% of its industry peers.
With a decent Return On Equity value of 13.07%, PLAB is doing good in the industry, outperforming 77.27% of the companies in the same industry.
PLAB has a Return On Invested Capital of 10.39%. This is amongst the best in the industry. PLAB outperforms 81.82% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PLAB is in line with the industry average of 11.29%.
Industry RankSector Rank
ROA 8.64%
ROE 13.07%
ROIC 10.39%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
PLAB Yearly ROA, ROE, ROICPLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

With a decent Profit Margin value of 17.08%, PLAB is doing good in the industry, outperforming 76.36% of the companies in the same industry.
In the last couple of years the Profit Margin of PLAB has grown nicely.
Looking at the Operating Margin, with a value of 25.06%, PLAB belongs to the top of the industry, outperforming 85.45% of the companies in the same industry.
In the last couple of years the Operating Margin of PLAB has grown nicely.
Looking at the Gross Margin, with a value of 36.19%, PLAB is doing worse than 62.73% of the companies in the same industry.
PLAB's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 25.06%
PM (TTM) 17.08%
GM 36.19%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
PLAB Yearly Profit, Operating, Gross MarginsPLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

8

2. Health

2.1 Basic Checks

PLAB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, PLAB has more shares outstanding
PLAB has less shares outstanding than it did 5 years ago.
PLAB has a better debt/assets ratio than last year.
PLAB Yearly Shares OutstandingPLAB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PLAB Yearly Total Debt VS Total AssetsPLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.18 indicates that PLAB is not in any danger for bankruptcy at the moment.
The Altman-Z score of PLAB (3.18) is comparable to the rest of the industry.
PLAB has a debt to FCF ratio of 0.02. This is a very positive value and a sign of high solvency as it would only need 0.02 years to pay back of all of its debts.
PLAB has a better Debt to FCF ratio (0.02) than 85.45% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that PLAB is not too dependend on debt financing.
PLAB has a Debt to Equity ratio of 0.00. This is in the better half of the industry: PLAB outperforms 71.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Altman-Z 3.18
ROIC/WACC0.93
WACC11.23%
PLAB Yearly LT Debt VS Equity VS FCFPLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 5.66 indicates that PLAB has no problem at all paying its short term obligations.
PLAB's Current ratio of 5.66 is amongst the best of the industry. PLAB outperforms 82.73% of its industry peers.
PLAB has a Quick Ratio of 5.31. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of PLAB (5.31) is better than 85.45% of its industry peers.
Industry RankSector Rank
Current Ratio 5.66
Quick Ratio 5.31
PLAB Yearly Current Assets VS Current LiabilitesPLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

PLAB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.98%.
Measured over the past years, PLAB shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.90% on average per year.
PLAB shows a decrease in Revenue. In the last year, the revenue decreased by -2.82%.
PLAB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.50% yearly.
EPS 1Y (TTM)-0.98%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%-13.04%
Revenue 1Y (TTM)-2.82%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-2.77%

3.2 Future

The Earnings Per Share is expected to grow by 7.54% on average over the next years.
The Revenue is expected to grow by 3.81% on average over the next years.
EPS Next Y5.09%
EPS Next 2Y7.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.13%
Revenue Next 2Y3.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PLAB Yearly Revenue VS EstimatesPLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
PLAB Yearly EPS VS EstimatesPLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.63, the valuation of PLAB can be described as very reasonable.
Based on the Price/Earnings ratio, PLAB is valued cheaply inside the industry as 97.27% of the companies are valued more expensively.
PLAB is valuated cheaply when we compare the Price/Earnings ratio to 26.20, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 7.61 indicates a rather cheap valuation of PLAB.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 95.45% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of PLAB to the average of the S&P500 Index (22.13), we can say PLAB is valued rather cheaply.
Industry RankSector Rank
PE 8.63
Fwd PE 7.61
PLAB Price Earnings VS Forward Price EarningsPLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PLAB is valued cheaper than 98.18% of the companies in the same industry.
PLAB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PLAB is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.31
EV/EBITDA 1.46
PLAB Per share dataPLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PLAB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PLAB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.69
PEG (5Y)0.25
EPS Next 2Y7.54%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PLAB!.
Industry RankSector Rank
Dividend Yield N/A

PHOTRONICS INC

NASDAQ:PLAB (5/29/2025, 5:22:42 PM)

After market: 17.53 +0.1 (+0.57%)

17.43

+0.49 (+2.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-28 2025-05-28/bmo
Earnings (Next)08-27 2025-08-27/bmo
Inst Owners93.24%
Inst Owner Change-1.46%
Ins Owners3.79%
Ins Owner Change5%
Market Cap1.11B
Analysts85
Price Target36.21 (107.75%)
Short Float %5.29%
Short Ratio4.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.85%
Min EPS beat(2)8.47%
Max EPS beat(2)11.24%
EPS beat(4)2
Avg EPS beat(4)-2.14%
Min EPS beat(4)-17.55%
Max EPS beat(4)11.24%
EPS beat(8)4
Avg EPS beat(8)4.24%
EPS beat(12)6
Avg EPS beat(12)4.17%
EPS beat(16)9
Avg EPS beat(16)6.19%
Revenue beat(2)1
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.96%
Max Revenue beat(2)0.12%
Revenue beat(4)1
Avg Revenue beat(4)-4.2%
Min Revenue beat(4)-8.07%
Max Revenue beat(4)0.12%
Revenue beat(8)2
Avg Revenue beat(8)-2.34%
Revenue beat(12)5
Avg Revenue beat(12)-0.89%
Revenue beat(16)7
Avg Revenue beat(16)-0.57%
PT rev (1m)0%
PT rev (3m)1.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.73%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.69%
Valuation
Industry RankSector Rank
PE 8.63
Fwd PE 7.61
P/S 1.28
P/FCF 6.31
P/OCF 3.71
P/B 0.98
P/tB 0.98
EV/EBITDA 1.46
EPS(TTM)2.02
EY11.59%
EPS(NY)2.29
Fwd EY13.14%
FCF(TTM)2.76
FCFY15.84%
OCF(TTM)4.69
OCFY26.94%
SpS13.57
BVpS17.74
TBVpS17.74
PEG (NY)1.69
PEG (5Y)0.25
Profitability
Industry RankSector Rank
ROA 8.64%
ROE 13.07%
ROCE 14.02%
ROIC 10.39%
ROICexc 17.81%
ROICexgc 17.81%
OM 25.06%
PM (TTM) 17.08%
GM 36.19%
FCFM 20.34%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
ROICexc(3y)20.57%
ROICexc(5y)15.24%
ROICexgc(3y)20.57%
ROICexgc(5y)15.24%
ROCE(3y)17.42%
ROCE(5y)13.37%
ROICexcg growth 3Y30.41%
ROICexcg growth 5Y29.52%
ROICexc growth 3Y30.45%
ROICexc growth 5Y29.79%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
F-Score5
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Debt/EBITDA 0
Cap/Depr 148.28%
Cap/Sales 14.25%
Interest Coverage 250
Cash Conversion 99.77%
Profit Quality 119.09%
Current Ratio 5.66
Quick Ratio 5.31
Altman-Z 3.18
F-Score5
WACC11.23%
ROIC/WACC0.93
Cap/Depr(3y)153.58%
Cap/Depr(5y)131.47%
Cap/Sales(3y)14.5%
Cap/Sales(5y)14.32%
Profit Quality(3y)124.28%
Profit Quality(5y)132.15%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.98%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%-13.04%
EPS Next Y5.09%
EPS Next 2Y7.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.82%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-2.77%
Revenue Next Year1.13%
Revenue Next 2Y3.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.07%
EBIT growth 3Y32.79%
EBIT growth 5Y33.57%
EBIT Next Year34.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.1%
FCF growth 3Y46.47%
FCF growth 5YN/A
OCF growth 1Y22.4%
OCF growth 3Y20.13%
OCF growth 5Y30.76%